Rare diseases
Investigational molecules
Locations
Lichtstrasse 35, 4056
Novartis Pharma AG funds a broad oncology portfolio spanning solid tumours and blood cancers, with particular interest in breast cancer, prostate cancer, lung cancer, colorectal cancer, ovarian cancer, melanoma, and glioblastoma. Its studies also extend across lymphoma, leukemia, multiple myeloma, and other advanced malignancies.
The trial portfolio includes cancers defined by molecular features such as KRAS G12C, PIK3CA, EGFR, BRAF, IDH1, and PSMA expression, alongside radioligand and immunotherapy-related research in metastatic disease.
Novartis Pharma AG runs clinical trials in conditions such as Non-small cell lung cancer, Arteriosclerosis, Chronic myeloid leukaemia, Neoplasm malignant, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceFrance
Czechia
Bulgaria
AustriaFranceAustriaBulgariaFranceAustriaBulgaria
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
